Clinical Study

Asenapine For Bipolar Depression

Posted Date: May 15, 2013

  • Investigator: Caleb Adler
  • Co-Investigator: Laura Imhoff
  • Specialties: Depression, Psychiatry/Psychology, Bipolar Disorder
  • Type of Study: Drug

This research is being done to test the use of asenapine to treat bipolar depression. Asenapine is not US Food and Drug Administration (FDA) approved to treat bipolar depression.

Criteria:

You Are Being Asked To Take Part In This Research Study Because You Have Been Diagnosed With Bipolar Disorder And Are Currently Experiencing Depression. To Participate In This Study You Must Be At Least 18 Years Old, And No Older Than 55.

Keywords:

Asenapine, Depression, Adults, Medication, Bipolar

For More Information:

Emily Rummelhoff
(513) 558-4295
emily.rummelhoff@uc.edu

  • Search Clinical Studies

  • Research in the News

    UC Study Finds Direct Oral Anticoagulants May Help Some AF Patients

    UC researchers have tested a computerized decision analytic model to determinethe benefit direct oral anticoagulants has for patients with atrialfibrillation.